Literature DB >> 23288136

Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy.

N H Kang1, Y T Kim.   

Abstract

PURPOSE: To assess the change in subfoveal choroidal thickness (SFCT) in central serous chorioretinopathy (CSC) following spontaneous resolution and low-fluence photodynamic therapy (PDT) using the enhanced depth imaging optical coherence tomography (EDI-OCT).
METHODS: A total of 36 consecutive eyes of 36 patients were included in this retrospective study: 16 eyes with spontaneously resolved CSC and 20 eyes with PDT-treated CSC. Best-corrected visual acuity and SFCT were evaluated at each visit until complete absorption of the subretinal fluid. SFCT of 32 normal subjects were also measured, as the control group. Wilcoxon's singed-rank test was used to evaluate the effects of spontaneous resolution and PDT. To compare the SFCT of the eyes with resolved CSC with that of the normal eyes, Mann-Whitney U-test with Bonferroni correction was also employed.
RESULTS: SFCT of patients was 459.16±77.50 μm at the baseline, and decreased to 419.31±54.49μm after a spontaneous resolution (P=0.015). However, SFCT was not normalized in comparison with that of the normal subjects (P<0.001). SFCT in PDT group was also reduced from 416.43±74.01 to 349.50±88.99 μm (P<0.001), with no significant difference with the normal value (P=0.087).
CONCLUSIONS: SFCT in patients with CSC decreased both after spontaneous resolution and low-fluence PDT. However, only in the PDT group, after disappearance of subretinal fluid, did it decrease to that of normal subjects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23288136      PMCID: PMC3597877          DOI: 10.1038/eye.2012.273

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  26 in total

1.  Repeatability and reproducibility of subfoveal choroidal thickness in normal eyes of Japanese using different SD-OCT devices.

Authors:  Toshifumi Yamashita; Takehiro Yamashita; Makoto Shirasawa; Noboru Arimura; Hiroto Terasaki; Taiji Sakamoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-01       Impact factor: 4.799

Review 2.  Review and update of central serous chorioretinopathy.

Authors:  Alexander Ross; Adam H Ross; Quresh Mohamed
Journal:  Curr Opin Ophthalmol       Date:  2011-05       Impact factor: 3.761

3.  Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems.

Authors:  Lauren Branchini; Caio V Regatieri; Ignacio Flores-Moreno; Bernhard Baumann; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2011-09-23       Impact factor: 12.079

4.  Pathogenesis of disciform detachment of the neuroepithelium.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1967-03       Impact factor: 5.258

5.  One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.

Authors:  Ichiro Maruko; Tomohiro Iida; Yukinori Sugano; Minoru Furuta; Tetsuju Sekiryu
Journal:  Retina       Date:  2011-10       Impact factor: 4.256

Review 6.  Type-A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Retina       Date:  1987       Impact factor: 4.256

7.  Central serous chorioretinopathy and indocyanine green angiography.

Authors:  F C Piccolino; L Borgia
Journal:  Retina       Date:  1994       Impact factor: 4.256

8.  Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Ricky Y K Lai; David T L Liu; Dennis S C Lam
Journal:  Ophthalmology       Date:  2008-06-05       Impact factor: 12.079

9.  Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial.

Authors:  Michele Reibaldi; Nicola Cardascia; Antonio Longo; Claudio Furino; Teresio Avitabile; Salvatore Faro; Marisa Sanfilippo; Andrea Russo; Maurizio Giacinto Uva; Ferdinando Munno; Vincenzo Cannemi; Marco Zagari; Francesco Boscia
Journal:  Am J Ophthalmol       Date:  2009-11-06       Impact factor: 5.258

10.  Topographical Choroidal Thickness Change Following PDT for CSC: An OCT Case Report.

Authors:  William J Wirostko; Rick N Nordgren; Adam M Dubis
Journal:  J Ophthalmol       Date:  2012-01-12       Impact factor: 1.909

View more
  18 in total

1.  Reply to 'Change in subfoveal choroidal thickness in central serous chorioretinopathy'.

Authors:  Y T Kim
Journal:  Eye (Lond)       Date:  2013-08-02       Impact factor: 3.775

2.  Change in subfoveal choroidal thickness in central serous chorioretinopathy.

Authors:  C S H Tan; K X Cheong; S R Sadda
Journal:  Eye (Lond)       Date:  2013-08-02       Impact factor: 3.775

3.  The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study.

Authors:  A Ozkaya; Z Alkin; M Ozveren; A T Yazici; M Taskapili
Journal:  Eye (Lond)       Date:  2016-04-22       Impact factor: 3.775

4.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

5.  Axial length in unilateral idiopathic central serous chorioretinopathy.

Authors:  Hoseok Moon; Dae Yeong Lee; Dong Heun Nam
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

6.  Evaluation of choroidal thickness in patients with scleroderma.

Authors:  E Coşkun; O Zengin; S Kenan; G Kimyon; K Erdogan Er; S Okumus; A Mesut Onat; I Erbagcı; B Kısacık
Journal:  Eye (Lond)       Date:  2016-01-22       Impact factor: 3.775

7.  Correlation between choroidal structure and smoking in eyes with central serous chorioretinopathy.

Authors:  Kazuyoshi Okawa; Tatsuya Inoue; Ryo Asaoka; Keiko Azuma; Ryo Obata; Rei Arasaki; Shouko Ikeda; Arisa Ito; Maiko Maruyama-Inoue; Yasuo Yanagi; Kazuaki Kadonosono
Journal:  PLoS One       Date:  2021-03-23       Impact factor: 3.240

8.  Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.

Authors:  Alejandra Daruich; Alexandre Matet; Ali Dirani; Mathilde Gallice; Luke Nicholson; Sobha Sivaprasad; Francine Behar-Cohen
Journal:  Transl Vis Sci Technol       Date:  2016-03-04       Impact factor: 3.283

Review 9.  Advances in the treatment of central serous chorioretinopathy.

Authors:  Marwan A Abouammoh
Journal:  Saudi J Ophthalmol       Date:  2015-01-24

10.  Automatic analysis of selected choroidal diseases in OCT images of the eye fundus.

Authors:  Robert Koprowski; Slawomir Teper; Zygmunt Wróbel; Edward Wylegala
Journal:  Biomed Eng Online       Date:  2013-11-14       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.